DCM Shriram Fine Chemicals ratifies ₹3.02 lakh fine to exchanges for LODR breach
- DCM Shriram Fine Chemicals ratifies ₹3,02,080 fine to BSE and NSE each
- Penalty relates to delayed compliance with SEBI LODR Regulation 17(1)
- Non-compliance existed during Q2FY26 due to vacant independent director seat
- Gap resolved with appointment of Nitin Atroley effective July 15, 2026

*this image is generated using AI for illustrative purposes only.
DCM Shriram Fine Chemicals board ratified the payment of ₹3,02,080 to both BSE and NSE on September 21, 2026, settling penalties for non-compliance with SEBI’s Listing Obligations and Disclosure Requirements (LODR). The fines address a temporary gap in independent director representation during Q2FY27.
The company disclosed that the non-compliance stemmed from delays in identifying a suitable candidate for the position of Independent Director. This gap affected compliance with Regulation 17(1) of the SEBI (LODR) Regulations, 2015, for the quarter ended June 30, 2026.
Compliance Timeline
The board noted that the requirement under Regulation 17(1A) had been complied with on May 29, 2026. However, the violation of Regulation 17(1) persisted until the appointment of Mr. Nitin Atroley as Independent Director effective July 15, 2026.
| Regulation | Status | Date Complied | Fine Amount |
|---|---|---|---|
| LODR Reg 17(1A) | Compliant | May 29, 2026 | ₹3,02,080 (to each exchange) |
| LODR Reg 17(1) | Delayed | July 15, 2026 | ₹3,02,080 (to each exchange) |
Company Secretary Kokila Arora confirmed that the company was fully compliant with applicable provisions as of the date the exchange notices were received on August 25, 2026.
Board Directive
The board took the notices on record and approved the management’s decision to pay the fines to conclude the matter. It directed management to ensure strict adherence to all SEBI (LODR) regulations moving forward to prevent recurrence.
Historical Stock Returns for DCM Shriram Fine Chemicals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +4.97% | +10.96% | +5.50% | +17.52% | -42.23% | -42.23% |
Will DCM Shriram Fine Chemicals implement new internal governance protocols or third-party audits to prevent future gaps in independent director representation?
How might this regulatory penalty impact the company's credit ratings or investor confidence in its corporate governance framework?
Are there any pending legal repercussions or additional scrutiny from SEBI regarding the delay in appointing Mr. Nitin Atroley?


































